|
Quotes & Info
|
| GORX > SEC Filings for GORX > Form 8-K on 27-Jan-2009 | All Recent SEC Filings |
27-Jan-2009
Entry into a Material Definitive Agreement, Financial Statements and Exhibits
On January 26, 2009, GeoPharma, Inc. (the "Company") entered into an agreement with Trident Biotech, Inc. ("Trident"). Under the terms of the agreement, Trident will purchase a majority stake in the Company's Ovarian Cancer business for a total of $2.5 million in cash and notes. The Company will maintain a forty percent ownership in the business.
(c) Exhibits. The following documents are filed as exhibits to this report:
99.1 Press release issued January 26, 2009.
|
|